Tag: polymerase chain reaction molecular diagnostics market forecast analysis

Uncover key drivers, emerging technologies, and competitive movements shaping the polymerase chain reaction molecular diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Polymerase Chain Reaction Molecular Diagnostics Market’s size between 2026 and 2030?

The polymerase chain reaction molecular diagnostics market has shown robust growth in its size during recent years. Projections indicate it will expand from $9.75 billion in 2025 to $10.59 billion in 2026, with a compound annual growth rate (CAGR) of 8.7%. Its growth during the historical period stems from factors like the expansion of hospital-based molecular diagnostics, the increasing prevalence of infectious diseases, the availability of standardized pcr diagnostic kits, the growth of centralized diagnostic laboratories, and regulatory approvals for molecular tests.

The market for polymerase chain reaction molecular diagnostics is projected to experience robust expansion in the coming years. This market is anticipated to reach a valuation of $14.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. The predicted growth during this period stems from several factors, including the rising acceptance of point-of-care molecular diagnostics, increased funding for personalized medicine, the broadening of genomic testing initiatives, a greater need for decentralized diagnostics, and the enhanced incorporation of digital health platforms. Key trends expected within the forecast period involve a greater application of pcr in detecting infectious diseases, an escalating requirement for high-sensitivity molecular diagnostics, the broadening scope of pcr-based oncology examinations, the increasing incorporation of automated diagnostic systems, and a heightened emphasis on tests with swift results.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp

Which Drivers Are Shaping Strategic Decisions In The Polymerase Chain Reaction Molecular Diagnostics Market?

The polymerase chain reaction molecular diagnostics market is anticipated to expand due to the increasing prevalence of infectious diseases. These illnesses are caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly between individuals. The rise in infectious disease cases is attributed to the emergence of antibiotic-resistant pathogens, which are more challenging to treat and control, leading to prolonged sickness, increased healthcare expenses, and greater public health risks. Polymerase chain reaction (PCR) molecular diagnostics enhance the management of infectious diseases by offering rapid and accurate detection of pathogens at the genetic level, thus facilitating early diagnosis and targeted treatment. This improves healthcare outcomes by enabling timely interventions, reducing infection transmission, and optimizing patient care. For instance, the Centers for Disease Control and Prevention, a US-based government agency, indicated in April 2025 that 2,214 new cases of acute hepatitis B were reported in 2023, with an additional 1,769 hepatitis B-related deaths reported during the same year. Consequently, the rising prevalence of infectious diseases is a key factor driving the growth of the polymerase chain reaction molecular diagnostics market.

What Segment Categories Are Covered In The Polymerase Chain Reaction Molecular Diagnostics Market?

The polymerase chain reaction molecular diagnostics market covered in this report is segmented –

1) By Product Type: Instrument, Reagents And Consumables, Software

2) By Technology: Real-Time Polymerase Chain Reaction, Digital Polymerase Chain Reaction, Conventional Polymerase Chain Reaction

3) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Urine Samples

4) By Application: Infectious Disease Testing, Oncology Testing, Other Applications

5) By End-User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Instrument: Standard Polymerase Chain Reaction Systems, Digital Polymerase Chain Reaction Systems, Real-Time Polymerase Chain Reaction Systems

2) By Reagents And Consumables: Polymerase Chain Reaction Kits, Polymerase Chain Reaction Enzymes, Polymerase Chain Reaction Primers and Probes, Polymerase Chain Reaction Master Mix

3) By Software: Polymerase Chain Reaction Analysis Software, Data Management Software

Which Trends Are Influencing The Development Of The Polymerase Chain Reaction Molecular Diagnostics Market?

Leading firms within the polymerase chain reaction molecular diagnostics market are prioritizing the creation of advanced technological solutions, including benchtop instruments, to improve both the effectiveness and availability of testing. Benchtop instruments are defined as compact, laboratory-quality devices designed to be small enough for placement on a workbench or table, serving purposes in scientific, medical, or industrial testing and analysis. An example is QIAGEN N.V., a biotechnology company based in Germany, which introduced the QIAcuityDx Digital PCR System in September 2024, intended for clinical oncology testing. This system boasts fully automated, hands-off processing, consolidating partitioning, thermocycling, and imaging functions into one device. It provides absolute quantification of deoxyribonucleic acid and ribonucleic acid, yielding results in approximately two hours with very little manual intervention. Furthermore, the system accommodates up to five detection channels for multiplexing and supports continuous nanoplate loading. It provides both validated and customizable research modes, thereby offering versatility for various clinical and laboratory requirements.

Which Major Firms Are Strengthening Their Position In The Polymerase Chain Reaction Molecular Diagnostics Market?

Major companies operating in the polymerase chain reaction molecular diagnostics market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., bioMereieux SA, Sysmex Corporation, Bio Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, Zymo Research Corporation, QIAGEN N.V., Cepheid Inc., Meridian Bioscience Inc., LGC Biosearch Technologies, Analytik Jena AG, Promega Corporation, BGI Genomics Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-molecular-diagnostics-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Polymerase Chain Reaction Molecular Diagnostics Market?

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Polymerase Chain Reaction Molecular Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24383&type=smp

Browse Through More Reports Similar to the Global Polymerase Chain Reaction Molecular Diagnostics Market 2026, By The Business Research Company

In Vitro Diagnostics Enzymes Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report

Polymerase Chain Reaction Pcr Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-technologies-global-market-report

Dna Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the polymerase chain reaction molecular diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Polymerase Chain Reaction Molecular Diagnostics Market’s size between 2026 and 2030?

The polymerase chain reaction molecular diagnostics market has shown robust growth in its size during recent years. Projections indicate it will expand from $9.75 billion in 2025 to $10.59 billion in 2026, with a compound annual growth rate (CAGR) of 8.7%. Its growth during the historical period stems from factors like the expansion of hospital-based molecular diagnostics, the increasing prevalence of infectious diseases, the availability of standardized pcr diagnostic kits, the growth of centralized diagnostic laboratories, and regulatory approvals for molecular tests.

The market for polymerase chain reaction molecular diagnostics is projected to experience robust expansion in the coming years. This market is anticipated to reach a valuation of $14.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. The predicted growth during this period stems from several factors, including the rising acceptance of point-of-care molecular diagnostics, increased funding for personalized medicine, the broadening of genomic testing initiatives, a greater need for decentralized diagnostics, and the enhanced incorporation of digital health platforms. Key trends expected within the forecast period involve a greater application of pcr in detecting infectious diseases, an escalating requirement for high-sensitivity molecular diagnostics, the broadening scope of pcr-based oncology examinations, the increasing incorporation of automated diagnostic systems, and a heightened emphasis on tests with swift results.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp

Which Drivers Are Shaping Strategic Decisions In The Polymerase Chain Reaction Molecular Diagnostics Market?

The polymerase chain reaction molecular diagnostics market is anticipated to expand due to the increasing prevalence of infectious diseases. These illnesses are caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly between individuals. The rise in infectious disease cases is attributed to the emergence of antibiotic-resistant pathogens, which are more challenging to treat and control, leading to prolonged sickness, increased healthcare expenses, and greater public health risks. Polymerase chain reaction (PCR) molecular diagnostics enhance the management of infectious diseases by offering rapid and accurate detection of pathogens at the genetic level, thus facilitating early diagnosis and targeted treatment. This improves healthcare outcomes by enabling timely interventions, reducing infection transmission, and optimizing patient care. For instance, the Centers for Disease Control and Prevention, a US-based government agency, indicated in April 2025 that 2,214 new cases of acute hepatitis B were reported in 2023, with an additional 1,769 hepatitis B-related deaths reported during the same year. Consequently, the rising prevalence of infectious diseases is a key factor driving the growth of the polymerase chain reaction molecular diagnostics market.

What Segment Categories Are Covered In The Polymerase Chain Reaction Molecular Diagnostics Market?

The polymerase chain reaction molecular diagnostics market covered in this report is segmented –

1) By Product Type: Instrument, Reagents And Consumables, Software

2) By Technology: Real-Time Polymerase Chain Reaction, Digital Polymerase Chain Reaction, Conventional Polymerase Chain Reaction

3) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Urine Samples

4) By Application: Infectious Disease Testing, Oncology Testing, Other Applications

5) By End-User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Instrument: Standard Polymerase Chain Reaction Systems, Digital Polymerase Chain Reaction Systems, Real-Time Polymerase Chain Reaction Systems

2) By Reagents And Consumables: Polymerase Chain Reaction Kits, Polymerase Chain Reaction Enzymes, Polymerase Chain Reaction Primers and Probes, Polymerase Chain Reaction Master Mix

3) By Software: Polymerase Chain Reaction Analysis Software, Data Management Software

Which Trends Are Influencing The Development Of The Polymerase Chain Reaction Molecular Diagnostics Market?

Leading firms within the polymerase chain reaction molecular diagnostics market are prioritizing the creation of advanced technological solutions, including benchtop instruments, to improve both the effectiveness and availability of testing. Benchtop instruments are defined as compact, laboratory-quality devices designed to be small enough for placement on a workbench or table, serving purposes in scientific, medical, or industrial testing and analysis. An example is QIAGEN N.V., a biotechnology company based in Germany, which introduced the QIAcuityDx Digital PCR System in September 2024, intended for clinical oncology testing. This system boasts fully automated, hands-off processing, consolidating partitioning, thermocycling, and imaging functions into one device. It provides absolute quantification of deoxyribonucleic acid and ribonucleic acid, yielding results in approximately two hours with very little manual intervention. Furthermore, the system accommodates up to five detection channels for multiplexing and supports continuous nanoplate loading. It provides both validated and customizable research modes, thereby offering versatility for various clinical and laboratory requirements.

Which Major Firms Are Strengthening Their Position In The Polymerase Chain Reaction Molecular Diagnostics Market?

Major companies operating in the polymerase chain reaction molecular diagnostics market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., bioMereieux SA, Sysmex Corporation, Bio Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, Zymo Research Corporation, QIAGEN N.V., Cepheid Inc., Meridian Bioscience Inc., LGC Biosearch Technologies, Analytik Jena AG, Promega Corporation, BGI Genomics Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-molecular-diagnostics-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Polymerase Chain Reaction Molecular Diagnostics Market?

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Polymerase Chain Reaction Molecular Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24383&type=smp

Browse Through More Reports Similar to the Global Polymerase Chain Reaction Molecular Diagnostics Market 2026, By The Business Research Company

In Vitro Diagnostics Enzymes Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report

Polymerase Chain Reaction Pcr Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-technologies-global-market-report

Dna Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Polymerase Chain Reaction Molecular Diagnostics Market Be Worth By 2029?

In the past few years, there has been a significant increase in the market size of the polymerase chain reaction molecular diagnostics. By 2025, the market is projected to reach $9.75 billion, up from $8.97 billion in 2024, reflecting a compound annual growth rate (CAGR) of 8.6%. The past period’s growth has been driven by a multitude of factors such as rising demand for early detection of illnesses, enhanced prevalence of infectious diseases, heightened awareness about genetic disorders, amplifying adoption of point-of-care testing, and climbing incidence of chronic illnesses.

The anticipated growth of the polymerase chain reaction molecular diagnostics market over the coming years looks robust and is predicted to escalate to $13.54 billion by 2029, indicating an 8.6% compound annual growth rate (CAGR). Several factors contribute to this projected growth during the forecast period, including the escalating incidence of cancer, an increasing inclination towards personalized medicine, rising investment in molecular diagnostics, a burgeoning demand for swift diagnostic tests, and an expanding interest in non-invasive prenatal testing. Key forecast period trends comprise advancements in diagnostic technologies, evolution in point-of-care polymerase chain reaction systems, innovative strides in multiplex polymerase chain reaction, the amalgamation of polymerase chain reaction with microfluidics, and enhancements in digital polymerase chain reaction platform technologies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp

What Market Forces Are Contributing To The Growth Of The Polymerase Chain Reaction Molecular Diagnostics Market?

The upward trend of infectious diseases is anticipated to bolster the development of the polymerase chain reaction molecular diagnostics market. Infectious diseases are those caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites which can be directly or indirectly passed from one individual to another. The rise of these diseases is fueled by the emergence of antibiotic-resistant pathogens, posing a challenge to treatment and containment. These pathogens result in extended illnesses, elevated healthcare expenses, and increased public health dangers. Polymerase chain reaction (PCR) molecular diagnostics contribute to improved management of infectious diseases, by enabling prompt and precise detection of pathogens at the genetic level. This encourages early diagnosis and precise treatment, consequently enhancing healthcare outcomes through immediate interventions, limiting infection spread, and ensuring optimal patient care. For example, in November 2023, the Department of Health and Human Services, a government agency based in the US, reported that newly diagnosed chronic hepatitis B cases (a viral infection affecting the liver, leading to acute and chronic disease) increased by 11% in 2022 compared to 2021. As such, the growing incidence of infectious diseases is fuelling the expansion of the polymerase chain reaction molecular diagnostics market.

Which Segments Define The Structure Of The Polymerase Chain Reaction Molecular Diagnostics Market?

The polymerase chain reaction molecular diagnosticsmarket covered in this report is segmented –

1) By Product Type: Instrument; Reagents And Consumables; Software

2) By Technology: Real-Time Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Conventional Polymerase Chain Reaction

3) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Urine Samples

4) By Application: Infectious Disease Testing; Oncology Testing; Other Applications

5) By End-User: Hospitals; Diagnostic Laboratories; Other End Users

Subsegments:

1) By Instrument: Standard Polymerase Chain Reaction Systems; Digital Polymerase Chain Reaction Systems; Real-Time Polymerase Chain Reaction Systems

2) By Reagents And Consumables: Polymerase Chain Reaction Kits; Polymerase Chain Reaction Enzymes; Polymerase Chain Reaction Primers and Probes; Polymerase Chain Reaction Master Mix

3) By Software: Polymerase Chain Reaction Analysis Software; Data Management Software

Which Long-Term Trends Will Play A Crucial Role In The Polymerase Chain Reaction Molecular Diagnostics Market?

Major participants in the polymerase chain reaction molecular diagnostics market are prioritizing the development of technologically superior solutions, including benchtop instruments, to improve testing productivity and convenience. Benchtop instruments are compact, lab-compatible devices that can fit on a laboratory worktop or desk, which are utilized for scientific, medical, or industrial inspections and evaluations. For example, QIAGEN N.V., a biotechnology company from Germany, introduced the QIAcuityDx Digital PCR System designed for clinical oncology testing in September 2024. This system is completely automated, integrating partitioning, thermocycling, and imaging into one apparatus, providing precise quantification of deoxyribonucleic acid and ribonucleic acid with outcomes delivered within roughly two hours and negligible hands-on involvement. The system caters for up to five detection channels for multiplexing and supports ongoing nanoplate loading. It offers both validated and flexible research modes, rendering it flexible for a range of clinical and laboratory requirements.

Which Firms Are Making The Biggest Impact In The Polymerase Chain Reaction Molecular Diagnostics Market?

Major companies operating in the polymerase chain reaction molecular diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Grifols S.A., Illumina Inc., Endress + Hauser AG, bioMereieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, Zymo Research Corporation.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-molecular-diagnostics-global-market-report

Which Region Is Forecasted To Lead The Polymerase Chain Reaction Molecular Diagnostics Market In The Coming Years?

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24383&type=smp

Browse Through More Reports Similar to the Global Polymerase Chain Reaction Molecular Diagnostics Market 2025, By The Business Research Company

Polymerase Chain Reactions Devices Reagents And Uses Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reactions-devices-reagents-and-uses-global-market-report

Colorectal Cancer Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-molecular-diagnostics-global-market-report

Molecular Biology Enzymes And Kits And Reagents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-biology-enzymes-and-kits-and-reagents-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Polymerase Chain Reaction Molecular Diagnostics Market Expected To Expand Between 2025 And 2029?

The polymerase chain reaction molecular diagnostics market size has seen substantial growth in recent periods. It is projected to expand from $8.97 billion in 2024 to $9.75 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.6%. Historically, this expansion was driven by several factors, including the growing need for prompt disease identification, the rising occurrence of contagious illnesses, heightened understanding of hereditary conditions, the greater uptake of on-site diagnostic tests, and the escalating frequency of long-term health issues.

The polymerase chain reaction molecular diagnostics market size is projected for substantial expansion in the coming years. This market is anticipated to reach $13.54 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.6%. Several factors are expected to fuel this growth during the forecast period, including the increasing incidence of cancer, the escalating need for personalized medicine, boosted investments in molecular diagnostics, the expanding requirement for swift diagnostic tests, and the rising interest in non-invasive prenatal testing. Significant trends characterizing this period involve progress in diagnostic technologies, the creation of point-of-care polymerase chain reaction systems, advancements in multiplex polymerase chain reaction, the convergence of polymerase chain reaction with microfluidics, and enhancements in digital polymerase chain reaction platforms.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp

What Are The Top Growth Drivers Impacting The Polymerase Chain Reaction Molecular Diagnostics Market Outlook?

The increasing occurrence of infectious ailments is anticipated to drive the expansion of the polymerase chain reaction molecular diagnostics market in the future. Infectious diseases are conditions resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which possess the capability to transmit either directly or indirectly between individuals. The widespread nature of infectious diseases is escalating due to the appearance of antibiotic-resistant pathogens, which prove more challenging to manage and contain, thus resulting in extended sickness, elevated healthcare expenditures, and significant public health dangers. Polymerase chain reaction (PCR) molecular diagnostics improve the handling of infectious diseases through the provision of quick, precise identification of pathogens at their genetic level, facilitating prompt diagnosis and focused therapeutic approaches. This leads to better healthcare results by allowing for prompt medical actions, curbing the transmission of infections, and refining patient treatment. As an illustration, in November 2023, data from the Department of Health and Human Services, a US-based government department, indicated that newly reported chronic hepatitis B (a viral infection that affects the liver and can lead to both acute and chronic disease) instances increased by 11% in 2022 compared to 2021. Consequently, the growing occurrence of infectious diseases is fueling the expansion of the polymerase chain reaction molecular diagnostics market.

What Are The Major Segment Categories Driving The Polymerase Chain Reaction Molecular Diagnostics Market Growth?

The polymerase chain reaction molecular diagnosticsmarket covered in this report is segmented –

1) By Product Type: Instrument; Reagents And Consumables; Software

2) By Technology: Real-Time Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Conventional Polymerase Chain Reaction

3) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Urine Samples

4) By Application: Infectious Disease Testing; Oncology Testing; Other Applications

5) By End-User: Hospitals; Diagnostic Laboratories; Other End Users

Subsegments:

1) By Instrument: Standard Polymerase Chain Reaction Systems; Digital Polymerase Chain Reaction Systems; Real-Time Polymerase Chain Reaction Systems

2) By Reagents And Consumables: Polymerase Chain Reaction Kits; Polymerase Chain Reaction Enzymes; Polymerase Chain Reaction Primers and Probes; Polymerase Chain Reaction Master Mix

3) By Software: Polymerase Chain Reaction Analysis Software; Data Management Software

What Are The Major Trends Driving The Growth Of The Polymerase Chain Reaction Molecular Diagnostics Market?

Leading companies in the polymerase chain reaction molecular diagnostics market are concentrating on developing technologically advanced solutions, such as benchtop instruments, to boost testing efficiency and accessibility. Benchtop instruments are compact, laboratory-grade devices designed to fit on a workbench or table, employed for scientific, medical, or industrial testing and analysis. For instance, in September 2024, QIAGEN N.V., a Germany-based biotechnology company, unveiled the QIAcuityDx Digital PCR System for clinical testing in oncology. This system offers fully automated, walk-away processing that integrates partitioning, thermocycling, and imaging into a single instrument, providing absolute quantification of deoxyribonucleic acid and ribonucleic acid with results in about two hours and minimal hands-on time. The system supports up to five detection channels for multiplexing and continuous nanoplate loading, offering both validated and flexible research modes, thereby making it adaptable for diverse clinical and laboratory needs.

Who Are The Core Companies Influencing The Polymerase Chain Reaction Molecular Diagnostics Market Landscape?

Major companies operating in the polymerase chain reaction molecular diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Grifols S.A., Illumina Inc., Endress + Hauser AG, bioMereieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, Zymo Research Corporation.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-molecular-diagnostics-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Polymerase Chain Reaction Molecular Diagnostics Market?

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Polymerase Chain Reaction Molecular Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24383&type=smp

Browse Through More Reports Similar to the Global Polymerase Chain Reaction Molecular Diagnostics Market 2025, By The Business Research Company

Polymerase Chain Reactions Devices Reagents And Uses Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reactions-devices-reagents-and-uses-global-market-report

Colorectal Cancer Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-molecular-diagnostics-global-market-report

Molecular Biology Enzymes And Kits And Reagents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-biology-enzymes-and-kits-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Polymerase Chain Reaction Molecular Diagnostics Market Expected to Grow Between 2025 And 2029?

The size of the polymerase chain reaction molecular diagnostics market has experienced significant growth in recent times. The estimated projection is for it to escalate from $8.97 billion in 2024 to $9.75 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.6%. The growth experienced during the historic period is due to factors such as the rising demand for early disease diagnosis, an increase in infectious diseases, heightened awareness about genetic disorders, a rise in the adoption of point-of-care testing, and an increased incidence of chronic diseases.

The market size of the polymerase chain reaction molecular diagnostics is anticipated to witness considerable expansion in the coming years, reaching $13.54 billion in 2029 with a compound annual growth rate (CAGR) of 8.6%. This projected growth in the forecast period can be linked to the increasing incidence of cancer, rising demand for tailored medical treatment, heightened investment in molecular diagnostics, growing requirement for fast diagnostic tests, and expanding demand for non-invasive prenatal testing. Key trends projected for this forecast period consist of the maturing of diagnostic technologies, the evolution of point-of-care polymerase chain reaction systems, advances in multiplex polymerase chain reaction, the combination of polymerase chain reaction with microfluidics, and technological enhancements in digital polymerase chain reaction platforms.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Polymerase Chain Reaction Molecular Diagnostics Market?

The growth of the polymerase chain reaction molecular diagnostics market is expected to be fueled by the rising occurrences of infectious diseases. Diseases caused by harmful organisms such as bacteria, viruses, fungi, or parasites, which can be passed directly or indirectly from person to person, are increasing. The situation is being exacerbated by the arrival of antibiotic-resistant pathogens, which are tougher to manage and contain, resulting in extended illness, inflated healthcare costs, and increased risks to public health. Polymerase chain reaction (PCR) molecular diagnostics offers a more efficient way to manage infectious diseases, offering quick and precise identification of pathogens at the genetic level, which facilitates earlier diagnosis and focused treatment. This enhances healthcare outcomes by ensuring timely interventions, limiting the spread of infections, and improving patient care. For example, the Department of Health and Human Services, a government department in the U.S, reported in November 2023 that there was an 11% rise in newly reported chronic hepatitis B cases in 2022 compared to 2021. Hence, the escalating incidents of infectious diseases are propelling the growth of the polymerase chain reaction molecular diagnostics market.

Which Key Market Segments Comprise the Polymerase Chain Reaction Molecular Diagnostics Market and Drive Its Revenue Growth?

The polymerase chain reaction molecular diagnosticsmarket covered in this report is segmented –

1) By Product Type: Instrument; Reagents And Consumables; Software

2) By Technology: Real-Time Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Conventional Polymerase Chain Reaction

3) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Urine Samples

4) By Application: Infectious Disease Testing; Oncology Testing; Other Applications

5) By End-User: Hospitals; Diagnostic Laboratories; Other End Users

Subsegments:

1) By Instrument: Standard Polymerase Chain Reaction Systems; Digital Polymerase Chain Reaction Systems; Real-Time Polymerase Chain Reaction Systems

2) By Reagents And Consumables: Polymerase Chain Reaction Kits; Polymerase Chain Reaction Enzymes; Polymerase Chain Reaction Primers and Probes; Polymerase Chain Reaction Master Mix

3) By Software: Polymerase Chain Reaction Analysis Software; Data Management Software

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24383&type=smp

Which Areas Are Leading Regions in the Polymerase Chain Reaction Molecular Diagnostics Market Expansion Across the Globe?

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in thePolymerase Chain Reaction Molecular Diagnostics Market Over the Coming Years?

Key enterprises in the polymerase chain reaction molecular diagnostics market are dedicating their resources towards the development of technologically superior solutions like benchtop instruments to boost testing efficacy and accessibility. These benchtop instruments are compact devices, small enough to fit in a lab or on a table, but have the capabilities for extensive scientific, medical, or industrial testing and analysis. For example, in September 2024, the Germany-based biotechnology firm, QIAGEN N.V. introduced their QIAcuityDx Digital PCR System for oncology clinical testing. This system is designed for automated, no-hands-on processing, combining partitioning, thermocycling, and imaging into a single device. It provides absolute quantification of DNA and RNA with outcomes available in approximately two hours, requiring minimal hands-on time. The system can accommodate up to five detection channels simultaneously, facilitating multiplexing and continuous nanoplate loading. It also includes both validated and flexible research modes, making it suitable for varied clinical and laboratory requirements.

View the full report here:

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-molecular-diagnostics-global-market-report

How Is the Polymerase Chain Reaction Molecular Diagnostics Market Conceptually Defined?

Polymerase chain reaction (PCR) molecular diagnostics is a laboratory technique used to amplify and analyze specific deoxyribonucleic acid or ribonucleic acid sequences in a sample. Its main purpose is to detect the presence of specific genetic material, enabling the identification of pathogens, genetic disorders, or mutations. It is widely used in medical diagnostics for detecting infectious diseases, genetic disorders, and cancer markers with high sensitivity and accuracy.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24383

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

How Fast Is The Polymerase Chain Reaction Molecular Diagnostics Market Expected to Grow Between 2025 And 2029?

Over the past few years, the polymerase chain reaction molecular diagnostics market has been demonstrating immense growth. It is projected to escalate from $8.97 billion in 2024 to $9.78 billion in 2025, representing a compound annual growth rate (CAGR) of 9.0%. This robust growth during the historical period can be attributed to factors such as the rising demand for early disease detection, increased incidence of infectious diseases, greater awareness regarding genetic disorders, a growing preference for point-of-care testing, and a notable rise in chronic diseases.

The market size for polymerase chain reaction molecular diagnostics is predicted to experience robust growth in the upcoming years, reaching a projected $13.64 billion in 2029 with a compound annual growth rate (CAGR) of 8.7%. This growth throughout the forecast period can be linked to various factors including an increase in cancer cases, growing preference for personalized medicine, heightened investment in molecular diagnostics, a surge in demand for quick diagnostic tests, and a rise in demand for non-invasive prenatal tests. Key trends expected for the forecast period are improvements in diagnostic technologies, creation of point-of-care polymerase chain reaction systems, innovations in multiplex polymerase chain reaction, consolidation of polymerase chain reaction with microfluidics, and technological enhancements in digital polymerase chain reaction platforms.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp

Which Factors and External Forces Are Driving Demand in the Polymerase Chain Reaction Molecular Diagnostics Market?

As infectious diseases become more prevalent, they are anticipated to fuel the upward trajectory of the polymerase chain reaction molecular diagnostics market. Infectious diseases are caused by damaging microorganisms including bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly between individuals. Increasing incidences of these diseases can be attributed to the rise of antibiotic-resistant pathogens that are more difficult to treat and manage, resulting in extended illnesses, increased healthcare expenditures, and heightened risks to public health. Polymerase chain reaction (PCR) molecular diagnostics improves the management of infectious diseases by enabling swift and exact detection of pathogens at the genetic level. This allows for early diagnosis and precise treatments, leading to better healthcare outcomes by enabling timely interventions, slowing the spread of infections, and enhancing patient care. As an example, in November 2023, the Department of Health and Human Services, a US government department, revealed that the number of newly diagnosed chronic hepatitis B (a viral infection that impacts the liver, potentially causing acute and chronic disease) cases in 2022 saw an increase of 11% compared to the previous year. Consequently, the escalating prevalence of infectious diseases is a major factor contributing to the growth of the polymerase chain reaction molecular diagnostics market.

Which Segments in the Polymerase Chain Reaction Molecular Diagnostics Offer the Most Growth?

The polymerase chain reaction molecular diagnostics market covered in this report is segmented –

1) By Product Type: Instrument, Reagents And Consumables, Software

2) By Technology: Real-Time Polymerase Chain Reaction, Digital Polymerase Chain Reaction, Conventional Polymerase Chain Reaction

3) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Urine Samples

4) By Application: Infectious Disease Testing, Oncology Testing, Other Applications

5) By End-User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Instrument: Standard Polymerase Chain Reaction Systems, Digital Polymerase Chain Reaction Systems, Real-Time Polymerase Chain Reaction Systems

2) By Reagents And Consumables: Polymerase Chain Reaction Kits, Polymerase Chain Reaction Enzymes, Polymerase Chain Reaction Primers and Probes, Polymerase Chain Reaction Master Mix

3) By Software: Polymerase Chain Reaction Analysis Software, Data Management Software

Request customized data on this market:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp

What Are the Fastest-Growing Geographies in the Polymerase Chain Reaction Molecular Diagnostics Market?

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive the Polymerase Chain Reaction Molecular Diagnostics Market’s Growth?

Leading businesses in the polymerase chain reaction molecular diagnostics marketplace are putting their efforts towards producing technologically innovative solutions like benchtop instruments, in order to improve the effectiveness and accessibility of testing. The term ‘benchtop instruments’ denotes compact, laboratory-grade gadgets that can comfortably fit on a table or workbench and are employed for scientific, medical, or industry-related testing and analysation. For instance, the QIAcuityDx Digital PCR System, a product of the Germany-based biotech firm QIAGEN N.V., was introduced to the market in September 2024 for oncology-based clinical testing. The salient features of this system are its full automation and walk-away processing – measures that bring together partitioning, thermocycling, and imaging into one instrument, offering precise quantification of deoxyribonucleic acid and ribonucleic acid with outcomes delivered in approximately two hours and minimal hand-on time. The said system supports up to five detection channels for multiplexing, and continuous nanoplate loading – all the while offering both validated and flexible research modes, making it a versatile choice for various clinical and laboratory applications.

View the full report here:

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-molecular-diagnostics-global-market-report

What Are the Key Elements That Define the Polymerase Chain Reaction Molecular Diagnostics Market?

Polymerase chain reaction (PCR) molecular diagnostics is a laboratory technique used to amplify and analyze specific deoxyribonucleic acid or ribonucleic acid sequences in a sample. Its main purpose is to detect the presence of specific genetic material, enabling the identification of pathogens, genetic disorders, or mutations. It is widely used in medical diagnostics for detecting infectious diseases, genetic disorders, and cancer markers with high sensitivity and accuracy.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/customise?id=24383&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model